Zymedi
PrivateLast Round
Series A
Extension
May 30, 2023
Total Funding Raised
$28.85M
Company Overview
Zymedi is a biotechnology company that develops a novel therapeutics platform intended to improve the quality of life for people suffering from diseases by focusing on aminoacyl-tRNA synthetases (ARSs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zymedi Comparables
Compare Zymedi with similar companies based on industry and business-model similarity.
Zymedi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 30, 2023 | ||||
| Series A | Mar 26, 2021 | ||||
| Angel | Oct 1, 2020 |
Key People
Founding team and executive leadership
Zymedi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Company K Partners, Limited | Series A, Series A Extension |
| CKD Venture Capital | Series A Extension |
| UTC Investment | Series A, Series A Extension |
| Company K Partners | Series A, Series A Extension |
| Medytox Venture Investment | Series A Extension |
| Korea Development Bank | Series A Extension |
| Korea Venture Investment Corporation | Series A Extension |
Zymedi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zymedi's valuation, stock price, and market status.